117 related articles for article (PubMed ID: 20175785)
1. Analysis of inhibition of topoisomerase IIalpha and cancer cell proliferation by ingenolEZ.
Yoshida C; Hishiyama K; Miyazaki K; Watanabe M; Kanbe M; Yamada Y; Matsuzaki K; Miyashita K; Kitanaka S; Miyata S
Cancer Sci; 2010 Feb; 101(2):374-8. PubMed ID: 20175785
[TBL] [Abstract][Full Text] [Related]
2. Diterpenes from the roots of Euphorbia kansui and their in vitro effects on the cell division of Xenopus.
Wang LY; Wang NL; Yao XS; Miyata S; Kitanaka S
J Nat Prod; 2002 Sep; 65(9):1246-51. PubMed ID: 12350140
[TBL] [Abstract][Full Text] [Related]
3. The water expelling effect evaluation of 3-O-(2'E,4'Z-decadienoyl)-20-O-acetylingenol and ingenol on H22 mouse hepatoma ascites model and their content differences analysis in Euphorbia kansui before and after stir-fried with vinegar by UPLC.
Zhang Q; Ju YH; Zhang Y; Wang K; Zhang M; Chen PD; Yao WF; Tang YP; Wu JH; Zhang L
J Ethnopharmacol; 2021 Mar; 267():113507. PubMed ID: 33098970
[TBL] [Abstract][Full Text] [Related]
4. 3-O-(2'E,4'Z-decadienoyl)-20-O-acetylingenol induces apoptosis in intestinal epithelial cells of rats via mitochondrial pathway.
Gao J; Gao L; Zhang L; Yao W; Cao Y; Bao B; Ding A
J Ethnopharmacol; 2015 Nov; 174():331-8. PubMed ID: 26318745
[TBL] [Abstract][Full Text] [Related]
5. Ultra-performance liquid chromatography-quadrupole/time-of-flight mass spectrometry analysis of the impact of processing on toxic components of Kansui Radix.
Shu X; Jiang XW; Cheng BC; Ma SC; Chen GY; Yu ZL
BMC Complement Altern Med; 2016 Feb; 16():73. PubMed ID: 26912002
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of topoisomerase IIalpha and G2 cell cycle arrest by NK314, a novel benzo[c]phenanthridine currently in clinical trials.
Guo L; Liu X; Nishikawa K; Plunkett W
Mol Cancer Ther; 2007 May; 6(5):1501-8. PubMed ID: 17513599
[TBL] [Abstract][Full Text] [Related]
7. Three antinematodal diterpenes from Euphorbia kansui.
Shi JX; Li ZX; Nitoda T; Izumi M; Kanzaki H; Baba N; Kawazu K; Nakajima S
Biosci Biotechnol Biochem; 2007 Apr; 71(4):1086-9. PubMed ID: 17420578
[TBL] [Abstract][Full Text] [Related]
8. Daurinol, a catalytic inhibitor of topoisomerase IIα, suppresses SNU-840 ovarian cancer cell proliferation through cell cycle arrest in S phase.
Kang K; Nho CW; Kim ND; Song DG; Park YG; Kim M; Pan CH; Shin D; Oh SH; Oh HS
Int J Oncol; 2014 Aug; 45(2):558-66. PubMed ID: 24841075
[TBL] [Abstract][Full Text] [Related]
9. Phenolic-containing organic extracts of mulberry (Morus alba L.) leaves inhibit HepG2 hepatoma cells through G2/M phase arrest, induction of apoptosis, and inhibition of topoisomerase IIα activity.
Naowaratwattana W; De-Eknamkul W; De Mejia EG
J Med Food; 2010 Oct; 13(5):1045-56. PubMed ID: 20828312
[TBL] [Abstract][Full Text] [Related]
10. Toxicity Reduction of
Zhang Q; Zhang Y; Zhou SK; Wang K; Zhang M; Chen PD; Yao WF; Tang YP; Wu JH; Zhang L
Molecules; 2019 Oct; 24(20):. PubMed ID: 31652602
[TBL] [Abstract][Full Text] [Related]
11. Selective killing of G2 decatenation checkpoint defective colon cancer cells by catalytic topoisomerase II inhibitor.
Jain CK; Roychoudhury S; Majumder HK
Biochim Biophys Acta; 2015 May; 1853(5):1195-204. PubMed ID: 25746763
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and biological evaluation of C1-O-substituted-3-(3-butylamino-2-hydroxy-propoxy)-xanthen-9-one as topoisomerase IIα catalytic inhibitors.
Park S; Hong E; Kwak SY; Jun KY; Lee ES; Kwon Y; Na Y
Eur J Med Chem; 2016 Nov; 123():211-225. PubMed ID: 27484510
[TBL] [Abstract][Full Text] [Related]
13. Selection of human leukemic CEM cells for resistance to the DNA topoisomerase II catalytic inhibitor ICRF-187 results in increased levels of topoisomerase IIalpha and altered G(2)/M checkpoint and apoptotic responses.
Morgan SE; Cadena RS; Raimondi SC; Beck WT
Mol Pharmacol; 2000 Feb; 57(2):296-307. PubMed ID: 10648639
[TBL] [Abstract][Full Text] [Related]
14. Topoisomerase IIalpha maintains genomic stability through decatenation G(2) checkpoint signaling.
Bower JJ; Karaca GF; Zhou Y; Simpson DA; Cordeiro-Stone M; Kaufmann WK
Oncogene; 2010 Aug; 29(34):4787-99. PubMed ID: 20562910
[TBL] [Abstract][Full Text] [Related]
15. Metnase mediates resistance to topoisomerase II inhibitors in breast cancer cells.
Wray J; Williamson EA; Royce M; Shaheen M; Beck BD; Lee SH; Nickoloff JA; Hromas R
PLoS One; 2009; 4(4):e5323. PubMed ID: 19390626
[TBL] [Abstract][Full Text] [Related]
16. The anticancer thiosemicarbazones Dp44mT and triapine lack inhibitory effects as catalytic inhibitors or poisons of DNA topoisomerase IIα.
Yalowich JC; Wu X; Zhang R; Kanagasabai R; Hornbaker M; Hasinoff BB
Biochem Pharmacol; 2012 Jul; 84(1):52-8. PubMed ID: 22503743
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of cellular proliferation by diterpenes, topoisomerase II inhibitor.
Miyata S; Wang LY; Yoshida C; Kitanaka S
Bioorg Med Chem; 2006 Mar; 14(6):2048-51. PubMed ID: 16314107
[TBL] [Abstract][Full Text] [Related]
18. (S)-Erypoegin K, an isoflavone isolated from Erythrina poeppigiana, is a novel inhibitor of topoisomerase IIα: Induction of G2 phase arrest in human gastric cancer cells.
Hikita K; Yamakage Y; Okunaga H; Motoyama Y; Matsuyama H; Matsuoka K; Murata T; Nakayoshi T; Oda A; Kato K; Tanaka H; Asao N; Dan S; Kaneda N
Bioorg Med Chem; 2021 Jan; 30():115904. PubMed ID: 33341500
[TBL] [Abstract][Full Text] [Related]
19. Resveratrol induces DNA double-strand breaks through human topoisomerase II interaction.
Leone S; Cornetta T; Basso E; Cozzi R
Cancer Lett; 2010 Sep; 295(2):167-72. PubMed ID: 20304553
[TBL] [Abstract][Full Text] [Related]
20. Chinese hamster ovary cells resistant to the topoisomerase II catalytic inhibitor ICRF-159: a Tyr49Phe mutation confers high-level resistance to bisdioxopiperazines.
Sehested M; Wessel I; Jensen LH; Holm B; Oliveri RS; Kenwrick S; Creighton AM; Nitiss JL; Jensen PB
Cancer Res; 1998 Apr; 58(7):1460-8. PubMed ID: 9537249
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
